|
Orthologous residues
|
|
Smad2 (human): S465‑p, Smad2 (mouse): S465‑p, Smad2 (rat): S465‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
2D analysis, mutation of modification site, phospho-antibody, phosphoamino acid analysis, western blotting
|
|
Disease tissue studied:
liver cancer
|
|
Relevant cell lines - cell types - tissues:
COS (fibroblast), HepG2 (hepatic), Mv1Lu (epithelial)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
TGFBR1 (human)
|
phosphopeptide analysis, 2D analysis, mutation in upstream enzyme recognition motif, transfection of constitutively active enzyme
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
molecular association, regulation
|
|
Effect of modification (process):
transcription, altered
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
TGFBR1 (human)
|
|
Disrupts
|
molecular association, regulation
|
transcription, altered
|
co-immunoprecipitation
|
|
Smad4 (human)
|
|
Induces
|
molecular association, regulation
|
|
co-immunoprecipitation
|
|
|
Comments:
S464 not likely phosphorylated but is required for efficient phosphorylation of COOH terminus.
|